CJC-1295 with DAC: healthy-adult study regimens
Human schedule
CJC-1295 with DAC is given subcutaneously; albumin binding extends its half-life to ~6–8 days, so regimens are described as once-weekly dosing. The figures below are a generalized reference drawn from published pharmacokinetic data and protocols.
This is a concise reference to regimens described for adults; it is not an individual prescription.
| Period / condition | Dose | Escalation |
|---|---|---|
| Start | 1 mg (1000 mcg) subcutaneously, once weekly | Starting dose |
| Maintenance | 2 mg once weekly | Increase if needed |
| Split regimen | 2 mg per week, divided into 2 injections (1 mg each) | Maximum in this schedule |